Imaging Center COE

Prostate Cancer and Molecular Tracers: 11C/18F-Choline for Biochemical Recurrence - Laura Evangelista

Details
(Length of lecture ~ 17 minutes) Laura Evangelista, MD PhD presented " Prostate Cancer and Molecular Tracers: 11C/18F-Choline for Biochemical Recurrence” at the SNMMI 2016, Dr. Evangelista details the best radiopharmaceutical agent: 11C/18F-Choline and the clinical role and ability to affect patient management and survival of prostate cancer. Additional content on Prostate Cancer and Molecular Tra...

Imaging in High Risk Prostate Cancer: Clinicians Perspective - Mark Frydenberg

Details
More from the 2017 APCCC (Advanced Prostate Cancer Consensus Conference): Read the 2017 APCCC Report on Management of Patients with Advanced Prostate Cancer Access to all Advanced Prostate Cancer Consensus Conference Video Coverage

Oligometastatic and Oligo-progressive Prostate Cancer: Answer of the Radiologist - Anwar Padhani

Details
More from the speaker: Imaging of Metastatic Prostate Cancer- Anwar Padhar More from 2017 Advanced Prostate Cancer Consensus Conference (APCCC): Read the 2017 APCCC Report on Management of Patients with Advanced Prostate Cancer Access to all Advanced Prostate Cancer Consensus Conference Video Coverage

Oligometastatic and Oligo-progressive Prostate Cancer: Answer of the Nuclear Specialist - Stefano Fanti

Details
Read the 2017 APCCC Report on Management of Patients with Advanced Prostate Cancer Access to all Advanced Prostate Cancer Consensus Conference Video Coverage Radiopharmaceuticals in Prostate Cancer - Stefano Fanti

Therapeutic Layering in Optimizing Treatment for Patients With CPRC (RADAR II)- Phillip Koo

Details
E. David Crawford interviews Phillip Koo on the RADAR II paper and the key take-aways from the perspective of a nuclear medicine physician treating mCRPC. Biographies: Phillip Koo, MD E. David Crawford, MD

Multiparametric Prostate MRI: Current Status - Fergus Coakley

Details
The current status of Multiparametric Prostate MRI imaging Biographies: Phillip J. Koo Fergus V. Coakley, MD is the Chair of the Department of Diagnostic Radiology in the Oregon Health & Science University School of Medicine. He is a Professor in Residence in the Department of Radiology and Biomedical Imaging in the University of California San Francisco (UCSF) School of Medicine. Dr. Coakley is a...

PSMA PET in Prostate Cancer: Steve Cho

Details
Prostate-specific membrane antigen (PSMA) has received a resurgence of attention as a useful biomarker in the imaging evaluation of prostate cancer with PET. Philip Koo, MD, welcomes Steve Cho, MD to discuss PSMA PET in prostate cancer for the inaugural lecture for the Imaging Center of Excellence on UroToday. Dr. Cho's discusses the number of agents that are being developed in prostate cancer and...

Operationalization of Radium-223 Therapy for Bone Metastases - Eric Rohren

Details
An excerpt from Dr. Eric Rohren's state of the art presentation on Radium-223. This discussion includes the operationalization of Radium-223 at MD Anderson. In addition, a review of different agents available for imaging skeletal metastases with metastatic castration-resistant prostate cancer and a look at patient prognosis and survival data. Biography: Eric Rohren, MD. PhD., a national leader in...

Cristina Nanni on Flucicovine F18 (FACBC) in Prostate Cancer - State of the Art Presentation

Details
Cristina Nanni, MD. a leader in prostate cancer nuclear imaging, presents the data on Flucicovine F18 (FACBC), a new radiopharmaceutical and its application in diagnosisng biochemical replapse in post prostatectomy patients based upon a rising PSA. Dr. Nanni also presents details on its mechanism of action in prostate cancer cells, the current clinical approach and reviews of patient case studies...

Axumin™ (Fluciclovine F 18) Injection for PET Imaging of Recurrent Prostate Cancer - Phillip Koo

Details
In this 5 for 5 Hot Topics, Phillip Koo, MD. presents the clinical background of Axumin™ (Fluciclovine F 18) Injection for PET Imaging of Recurrent Prostate Cancer, the first FDA-approved F18 PET Imaging Agent indicated in for use in patients with suspected recurrent prostate cancer. Dr. Koo discusses its use for men with suspected prostate cancer recurrence based on elevated PSA levels following...
E-Newsletters

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.

Subscribe